SEC Form 4/A · accession 0001104659-16-104508
EPIRUS Biopharmaceuticals, Inc. · EPRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael Wyand
Officer — Chief Technical Officer
Period of report
Feb 27, 2016
Accepted (ET)
Mar 11, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001135906
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2016 | M | 1,044 | — | A | 31,432 | D | |
| Common StockF2 | Feb 27, 2016 | M | 2,608 | — | A | 34,040 | D | |
| Common StockF4,F5 | Feb 27, 2016 | F | 1,378 | $2.80 | D | 32,662 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each Restricted Stock Unit ("RSU") represented a contingent right to receive a share of the Issuer's common stock, vested in full on February 27, 2016, and had no expiration date.
- F2Each RSU represents a contingent right to receive a share of the Issuer's common stock, vests in four (4) substantially equal annual installments beginning on February 27, 2016 provided the Reporting Person remains continuously employed by the Issuer through each vesting date, and has no expiration date.
- F3Represents shares of the Issuer's common stock withheld by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portions of the RSUs as reflected in this Form 4.
- F4Represents the closing price of shares of the Issuer's common stock on the business day prior to the vesting date for such RSUs.
- F5The original Form 4 filed on March 1, 2016 is amended by this Form 4 amendment to correctly reflect the number of shares of the Issuer's common stock withheld by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portions of the RSUs and to correctly reflect the Reporting Person's ownership of the Issuer's common stock. No other changes have been made to the original Form 4.